Showing results (51-60 of 87) with videos related to

Sort By:
Pageof 9
Journal of Medical Internet Research|December 4, 2016
An eHealth Project on Invasive Pneumococcal Disease: Comprehensive Evaluation of a Promotional CampaignDonatella Panatto, Alexander Domnich, Roberto Gasparini, et al.
Healthcare (Basel, Switzerland)|June 12, 2026
Bridging the Gap Between Social Determinants and Health Profile: A New Stratification Tool for the Italian National Health ServiceElvira Massaro, Irene Schenone, Daniela Amicizia, et al.
Vaccines|June 27, 2025
Determinants of Accepting or Rejecting Influenza Vaccination-Results of a Survey Among Ligurian Pharmacy Visitors During the 2023/2024 Vaccination CampaignDaniela Amicizia, Silvia Allegretti, Federico Grammatico, et al.
BMC Health Services Research|August 21, 2019
Hospital and economic burden of influenza-like illness and lower respiratory tract infection in adults ≥50 years-oldCecilia Trucchi, Chiara Paganino, Andrea Orsi, et al.
BMC Infectious Diseases|December 10, 2013
Prevalence of human papillomavirus in young Italian women with normal cytology: how should we adapt the national vaccination policy?Donatella Panatto, Daniela Amicizia, Elisabetta Tanzi, et al.
Vaccines|December 28, 2021
Has Clinical and Epidemiological Varicella Burden Changed over Time in Children? Overview on Hospitalizations, Comorbidities and Costs from 2010 to 2017 in ItalyMaria Francesca Piazza, Daniela Amicizia, Chiara Paganino, et al.
Human Vaccines & Immunotherapeutics|October 30, 2020
Lowering the recommended age for the free and active offer of influenza vaccination in Italy: clinical and economic impact analysis in the Liguria regionCecilia Trucchi, Marco D'Amelio, Daniela Amicizia, et al.
Human Vaccines & Immunotherapeutics|December 9, 2014
Chlamydia trachomatis prevalence and chlamydial/HPV co-infection among HPV-unvaccinated young Italian females with normal cytologyDonatella Panatto, Daniela Amicizia, Silvia Bianchi, et al.
Human Vaccines & Immunotherapeutics|May 11, 2016
Vaccinating Italian infants with a new multicomponent vaccine (Bexsero®) against meningococcal B disease: A cost-effectiveness analysisRoberto Gasparini, Paolo Landa, Daniela Amicizia, et al.
Human Vaccines|January 27, 2011
Safety and tolerability of bivalent HPV vaccine: an Italian post-licensure studyRoberto Gasparini, Paolo Bonanni, Miriam Levi, et al.
Pageof 9